About us
ETAP-Lab is an independent Contract Research Organization (CRO)

ETAP-Lab provides preclinical pharmacology and research services, as well as scientific expertise, to Pharmaceutical and Agro-Food industries. Our activity focuses on In Vivo models of pathologies and toxicology studies in rodents to support drug and nutraceutic R&D for our sponsors.
Since the foundation in 1991, ETAP-Lab’s Scientists have an in-depth expertise in pathology modeling with rodents. By respecting rodent chronobiology and natural behaviors, ETAP-Lab proposes research models with added translational value. All our models are customizable and original specific models can be set-up and validated on request.
Subscribe to our newsletter
Our News
-
ETAP-Lab announces the acquisition of SYNCROSOME
ETAP-Lab announces the acquisition of SYNCROSOME, a CRO specialising in preclinical in vivo pharmacology services focused on cardiovascular pathologies. 🚀 This represents a significant step forward in the implementation of
-
BRYOFLAM : Maladies Inflammatoires et Neuro-Inflammatoires – L’espoir rĂ©side dans les mousses !
ETAP-Lab est fier de lancer officiellement le projet BRYOFLAM ! En collaboration avec Plant Advanced Technologies PAT et le laboratoire IMoPA-CNRS de l'Université de Lorraine, nous visons à découvrir de
-
Lancement lorrain de BIO-DIAMOND réussi sous le soleil de Nancy !
Hier, nous avons présenté avec notre partenaire NETRI le projet BIO-DIAMOND à notre écosystème local. Nous avons eu l'honneur d'accueillir Monsieur Christophe Choserot, président de Grand Nancy Innovation , Monsieur François Werner, vice-président de